Merck is to buy SmartCells for $500 million
NEW DELHI: Merck & Co. (MRK), pharmaceutical major, is all set to acquire SmartCells, a privately held diabetes treatment developer, for $500 million.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment